MKI67 and cancer: Cell morphology and p-MLC2 levels were assessed as amoeboid markers; ki-67 staining as a proliferative marker; WNT11, WNT5B and DAAM1 expression as non-canonical Wnt markers; and ALDH1A1, ALDH1A3, CD44, NANOG and OCT4 were evaluated as cancer stem cell-related markers.